A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. uri icon

authors

  • Chen, A C
  • Bielski, V A
  • Halliday, G M
  • Damian, D L
  • Martin, A J
  • Dalziell, R A
  • McKenzie, C A
  • Lowe, P M
  • Eris, J M
  • Scolyer, R A
  • Dhillon, H M
  • Vardy, J L

publication date

  • January 1, 2016